Health
Researchers develop promising new drug candidates to treat ALS – Drug Target Review
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Posted: 2 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Scientists have shown that a Selenium-based drug-molecule called ebselen and other novel compounds can delay ALS onset in mouse models.
Scientists report that they have taken a significant step forward in the search to find effective new drugs for the treatment of Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease.
Researchers from the University of Liverpool, UK, and University of Nagoya, Ja…
-
Noosa News16 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business23 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General22 hours agoStocks, dollar sink as trade war roils markets
-
General18 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle